Skip to main content
ANNX
NASDAQ Life Sciences

Annexon 公司第四季度每股亏损28美分,好于预期

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
7
Price
$4.96
Mkt Cap
$717.856M
52W Low
$1.285
52W High
$7.18
Market data snapshot near publication time

summarizeSummary

Annexon, Inc. 报告第四季度每股亏损28美分,据指好于分析师预期。预期之内的较小亏损通常是对投资者来说积极的信号,表明公司在本季度的财务表现或成本管理方面好于预期。这则新闻对像Annexon 这样规模的生物科技公司来说具有重要意义,因为收益表现会影响投资者情绪和估值。交易者现在将寻找完整的收益报告,以获取有关收入、现金燃烧和其临床管道更新的详细信息,这些对于长期估值至关重要。

在该公告发布时,ANNX的交易价格为$4.96,交易所为NASDAQ,所属行业为Life Sciences,市值约为$7.2亿。 52周交易区间为$1.29至$7.18。 这则新闻被评估为积极市场情绪,重要性评分为7/10。 来源:Dow Jones Newswires。


show_chartPrice Chart

Share this article

Copied!

feed ANNX - Latest Insights

ANNX
Apr 16, 2026, 4:06 PM EDT
Filing Type: PRE 14A
Importance Score:
9
ANNX
Mar 30, 2026, 7:42 PM EDT
Filing Type: S-3ASR
Importance Score:
7
ANNX
Mar 30, 2026, 5:30 PM EDT
Filing Type: 10-K
Importance Score:
7
ANNX
Mar 30, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
8
ANNX
Mar 30, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
ANNX
Mar 30, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
ANNX
Jan 14, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
ANNX
Jan 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8